MSOS

AdvisorShares Pure US Cannabis ETF (MSOS) | Rumor.io

AdvisorShares Pure US Cannabis ETF

MSOS

Attention (50-day avg)0.72%

Attention rank (50-day avg)#16

Bullish sentiment (50-day avg)74%

Price to earnings ratio0

Net assets0

Expense ratio0.01%

Social

What share of all ETF conversation is about MSOS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0.49% -0.18	0.73% +0.03	0.7% -0.05	0.19% +0.1

Sep 29

The AdvisorShares Pure US Cannabis ETF ($MSOS) has made adjustments to its holdings, with a current NAV of $5.14 and closing price of $5.16.
$MSOS has closed over $5, with some investors viewing this as a buying opportunity, while others are concerned about a 2-week delay in the rescheduling of marijuana.
The ETF's put players have emerged, and some investors are viewing a selloff in $TRLV as a gift, with $TRLV being in the clear with medical Schedule III a lock.

Generated by AI

Sentiment

Of the messages about MSOS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	69.59% +0.92	72.9% -4.45	68.69% -13.23	74.2% +1.85
Bearish	30.41% -0.92	27.1% +4.45	31.31% +13.23	25.8% -1.85

Bullish· Sep 28

The AdvisorShares Pure US Cannabis ETF ($MSOS) is showing signs of accumulation, with a strong short-term trend and a potential breakout from a bear flag.
The ETF is closely tied to the performance of Innovative Industrial Properties Inc. ($IIPR), a real estate investment trust that leases to state-licensed cannabis operators, and has a strong support level at the 200-day SMA.
The ETF is expected to benefit from a potential executive order legalizing cannabis, which could lead to a 1,000% increase in value.

Bearish· Sep 24

The AdvisorShares Pure US Cannabis ETF ($MSOS) has seen a decline in its EBITDA, from $18.1mm to $5.7mm, and a decrease in revenue, from $55-60mm to $47.0mm.
The ETF's recent performance has been impacted by the sale of its largest player, with inventory building up and production increasing, but not enough to offset the decline in sales.
The ETF's price has been volatile, with a significant drop from $7.25 to $4.85, and experts predict it will continue to drop, potentially flushing by the end of the day.

Generated by AI

Topics

Of the messages about MSOS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Technical Analysis	100%	99.7%	98.26%	98.06%
Macro	0%	0.3%	1.74%	1.94%

Macro· Jun 10

The US cannabis sector, represented by $MSOS, is influenced by macroeconomic factors such as inflation, interest rates, and the dollar index.
The sector's performance is also impacted by news and events related to the DEA Schedule III hearing, which could have a significant impact on the industry.
The uplisting of Trulieve ($TRLV) to the NYSE has provided a visibility boost to the sector, but its trading performance has been volatile, and the industry still faces uncertainty and challenges.

Technical Analysis· Sep 29

The author believes Judge Julius's opinion on marijuana rescheduling will be released soon, despite the delay, and will be a historic decision.
The $5 level is a crucial point of support for the ETF, and the battle to defend it is ongoing.
The author is optimistic about the charts and momentum building around cannabis reform, and believes it will have a positive impact on the ETF's price.

Generated by AI

Community

Of the messages about MSOS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	88.98%	89.4%	94.94%	86.85%
Newcomers	11.02%	10.6%	5.06%	13.15%

Regulars· Sep 29

The $MSOS ETF saw a 2% increase in value, closing at $5.16, with its NAV at $5.14, and the $MSOS put players emerged today.
A delay in the rescheduling of marijuana has been observed, with a hearing concluded, but the outcome is expected to be in favor of rescheduling, which would be positive for the $MSOS ETF.
The $MSOS ETF is still holding up well, with good volume and price action, and one participant has added more to their position, while another participant is patiently waiting for a potential take-profit (TPB) opportunity.

Newcomers· Aug 28

Many newcomers are focusing on the potential for a bounce in $MSOS after it respected the SMA20 in its latest uptrend.
Some users are questioning the performance of $MSOS, citing its supposed strong balance sheet and sales, and wondering why it's only up a few cents.
Others are looking to make trades based on their interpretation of the regulatory environment, including the potential for a judge's recommendation on September 18, and the launch and adoption of stablecoins.

Generated by AI

News

MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks (NYSEARCA:MSOS)

2mo agoSeeking Alpha

MSOS: Broader 280E Relief Could Add Meaningful Upside, But The Risk-Reward Suggests A Hold

2mo agoSeeking Alpha

Also Discussed

Investors talking about MSOS also mention

#	Name	Attention
1	AdvisorShares MSOS Daily Leveraged ETFMSOX	0.15%-0.05
2	MJUS - ETFMG U.S. Alternative Harvest ETF	——
3	Tilray Brands Inc.TLRY	0.02%0
4	Village Farms International Inc.VFF	0.01%-0.01
5	Canopy Growth CorporationCGC	0%-0.01
6	AdvisorShares Pure Cannabis ETFYOLO	0%0
7	Amplify Seymour Cannabis ETFCNBS	0.02%+0.01
8	High Tide Inc.HITI	0.01%-0.02
9	POTX - Global X Cannabis ETF	——
10	Amplify Alternative Harvest ETFMJ	0%new

AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF is an exchange-traded fund focusing on the U.S. cannabis industry. This ETF seeks to provide exposure to U.S.-based businesses involved in the legal cannabis sector, including companies engaged in cultivation, production, and distribution of cannabis for medical or recreational use, alongside ancillary businesses like agricultural supply, biotechnology, and real estate. Positioned as the first actively managed U.S. cannabis ETF, it employs a strategy that allows the fund managers to react to market developments and regulatory changes in real time. Its active management makes it distinctive in a space largely characterized by passive index replication. By investing primarily in companies listed on U.S. exchanges, the ETF supports businesses compliant with federal criteria, catering to investors interested in the burgeoning legal cannabis market domestically. Its holdings and weightings vary, reflecting an adaptable approach to capturing growth opportunities within the dynamic and complex cannabis ecosystem. This ETF provides a sector-specific investment vehicle, contributing to broader cannabis market awareness and integration within the financial landscape.

Location

United States

Social

What share of all ETF conversation is about MSOS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0.49% -0.18	0.73% +0.03	0.7% -0.05	0.19% +0.1

Sep 29

The AdvisorShares Pure US Cannabis ETF ($MSOS) has made adjustments to its holdings, with a current NAV of $5.14 and closing price of $5.16.
$MSOS has closed over $5, with some investors viewing this as a buying opportunity, while others are concerned about a 2-week delay in the rescheduling of marijuana.
The ETF's put players have emerged, and some investors are viewing a selloff in $TRLV as a gift, with $TRLV being in the clear with medical Schedule III a lock.

Generated by AI

Sentiment

Of the messages about MSOS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	69.59% +0.92	72.9% -4.45	68.69% -13.23	74.2% +1.85
Bearish	30.41% -0.92	27.1% +4.45	31.31% +13.23	25.8% -1.85

Bullish· Sep 28

The AdvisorShares Pure US Cannabis ETF ($MSOS) is showing signs of accumulation, with a strong short-term trend and a potential breakout from a bear flag.
The ETF is closely tied to the performance of Innovative Industrial Properties Inc. ($IIPR), a real estate investment trust that leases to state-licensed cannabis operators, and has a strong support level at the 200-day SMA.
The ETF is expected to benefit from a potential executive order legalizing cannabis, which could lead to a 1,000% increase in value.

Bearish· Sep 24

The AdvisorShares Pure US Cannabis ETF ($MSOS) has seen a decline in its EBITDA, from $18.1mm to $5.7mm, and a decrease in revenue, from $55-60mm to $47.0mm.
The ETF's recent performance has been impacted by the sale of its largest player, with inventory building up and production increasing, but not enough to offset the decline in sales.
The ETF's price has been volatile, with a significant drop from $7.25 to $4.85, and experts predict it will continue to drop, potentially flushing by the end of the day.

Generated by AI

Topics

Of the messages about MSOS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Technical Analysis	100%	99.7%	98.26%	98.06%
Macro	0%	0.3%	1.74%	1.94%

Macro· Jun 10

The US cannabis sector, represented by $MSOS, is influenced by macroeconomic factors such as inflation, interest rates, and the dollar index.
The sector's performance is also impacted by news and events related to the DEA Schedule III hearing, which could have a significant impact on the industry.
The uplisting of Trulieve ($TRLV) to the NYSE has provided a visibility boost to the sector, but its trading performance has been volatile, and the industry still faces uncertainty and challenges.

Technical Analysis· Sep 29

The author believes Judge Julius's opinion on marijuana rescheduling will be released soon, despite the delay, and will be a historic decision.
The $5 level is a crucial point of support for the ETF, and the battle to defend it is ongoing.
The author is optimistic about the charts and momentum building around cannabis reform, and believes it will have a positive impact on the ETF's price.

Generated by AI

Community

Of the messages about MSOS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	88.98%	89.4%	94.94%	86.85%
Newcomers	11.02%	10.6%	5.06%	13.15%

Regulars· Sep 29

The $MSOS ETF saw a 2% increase in value, closing at $5.16, with its NAV at $5.14, and the $MSOS put players emerged today.
A delay in the rescheduling of marijuana has been observed, with a hearing concluded, but the outcome is expected to be in favor of rescheduling, which would be positive for the $MSOS ETF.
The $MSOS ETF is still holding up well, with good volume and price action, and one participant has added more to their position, while another participant is patiently waiting for a potential take-profit (TPB) opportunity.

Newcomers· Aug 28

Many newcomers are focusing on the potential for a bounce in $MSOS after it respected the SMA20 in its latest uptrend.
Some users are questioning the performance of $MSOS, citing its supposed strong balance sheet and sales, and wondering why it's only up a few cents.
Others are looking to make trades based on their interpretation of the regulatory environment, including the potential for a judge's recommendation on September 18, and the launch and adoption of stablecoins.

Generated by AI

AdvisorShares Pure US Cannabis ETF

Social

Sep 29

Bullish· Sep 28

Bearish· Sep 24

Macro· Jun 10

Technical Analysis· Sep 29

Regulars· Sep 29

Newcomers· Aug 28

MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks (NYSEARCA:MSOS)

MSOS: Broader 280E Relief Could Add Meaningful Upside, But The Risk-Reward Suggests A Hold

Also Discussed

AdvisorShares Pure US Cannabis ETF

Company Information

Location

MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks (NYSEARCA:MSOS)

MSOS: Broader 280E Relief Could Add Meaningful Upside, But The Risk-Reward Suggests A Hold

Also Discussed

Social

Sep 29

Bullish· Sep 28

Bearish· Sep 24

Macro· Jun 10

Technical Analysis· Sep 29

Regulars· Sep 29

Newcomers· Aug 28